Island Urology

Summary

Island Urology is a medical facility located in Honolulu, Hawaii. This center is recognized for care of Lung Cancer, Breast Cancer, Breast cancer, Non-Small Cell Lung Cancer, Cancer and other specialties. Island Urology is involved with conducting 96 clinical trials across 241 conditions. There are 5 research doctors associated with this hospital, such as Jeffrey L. Berenberg, Jared D. Acoba, Kenneth N. Sumida, and Craig S. Boddy.

Top PIs

Clinical Trials running at Island Urology

Lung Cancer

Non-Small Cell Lung Cancer

Laryngeal Cancer

Breast cancer

Oropharyngeal Carcinoma

Breast Cancer

Cardiotoxicity

Squamous Cell Carcinoma

Throat Cancer

Lip and Oral Cavity Cancer

Immunotherapy + Chemotherapy

for Non-Small Cell Lung Cancer

This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.

Recruiting

2 awards

Phase 3

27 criteria

Radiation + Immunotherapy

for Non-Small Cell Lung Cancer

This phase II trial studies the side effects of radiation therapy followed by atezolizumab in treating patients with stage II or III non-small cell lung cancer. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more cancer cells and have fewer side effects. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The purpose of this study is to test the safety and effectiveness of radiation therapy followed by atezolizumab and find out what side effects, if any, it has on patient's non-small cell lung cancer.

Recruiting

1 award

Phase 2

39 criteria